MicroPort® MedBot® Announces Inclusion in Hang Seng Composite Index

Shanghai, China, 21 February 2022 - Shanghai MicroPort MedBot (Group) Co., Ltd. (MicroPort® MedBot®) has announced the company has been selected for inclusion in the Hang Seng Composite Index. This inclusion will take effect on Monday, 7 March, 2022.

According to relevant provisions of "Implementation Measures for Shanghai-Hong Kong Stock Connect Business (2021 revision)" and "Implementation Measures for Shenzhen-Hong Kong Stock Connect Business (2021 revision),” MicroPort® MedBot®, as a constituent stock of the Hang Seng Composite MidCap Index, is eligible for trading through Shanghai and Shenzhen Stock Connect. The company is expected to be officially entered into the list of Hong Kong Stock Connect after its inclusion in the Hang Seng Composite Index takes effect on 7 March, 2022.

This inclusion reflects the capital market's recognition and confidence in the development prospects of MicroPort® MedBot®, which will help the company achieve a more diversified shareholder base. At the same time, the entry of MicroPort® MedBot® onto the Hong Kong Stock Connect list also creates a new channel for mainland investors to invest in the company's shares.

Covering 95% of the companies with the highest market cap listed on the Main Board of the Stock Exchange of Hong Kong (HKEx), the Hang Seng Composite Index provides investors a comprehensive indicator of the Hong Kong stock market. Weighted by market capitalization, the Index can be used to issue index funds, mutual funds and performance benchmarks. Companies listed in the Hang Seng Composite Index are required to satisfy multiple requirements including market cap and share liquidity as stipulated in its calculation guidelines.

About MicroPort® MedBot®

By addressing the need for cutting-edge, minimally invasive surgeries, MicroPort® MedBot® (Stock code: 02252.HK) has been dedicated to driving research and industrial integration in the fields of robotics, intelligent control, sensing and information, to provide intelligent total surgical solutions that innovatively prolong and reshape life. Currently, MicroPort® MedBot® is the only surgical robot company in the world with businesses covering five promising subsectors of surgical robots, including endoscopy, orthopedics, vascular intervention, natural cavity, and percutaneous punctures.